BriaCell Therapeutics Corp. (TSX:BCT)
Canada
· Delayed Price · Currency is CAD 5.17
-0.30 (-5.48%)
At close: Mar 6, 2026
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 37.49 million as of March 6, 2026. Its market cap has increased by 38.62% in one year.
Market Cap
37.49M
Enterprise Value
22.35M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.17
Market Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has increased from 24.42M to 37.49M, an increase of 53.52%. That is a compound annual growth rate of 3.88%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Defence Therapeutics | 35.57M |
| Devonian Health Group | 33.19M |
| Resverlogix | 42.65M |
| Microbix Biosystems | 31.80M |
| MedMira | 45.33M |
| Telescope Innovations | 29.49M |
| Thiogenesis Therapeutics | 25.92M |
| NurExone Biologic | 56.27M |